{
  "ticker": "IRX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967360",
  "id": "02967360",
  "pages": 9,
  "price_sensitive": false,
  "date": "20250708",
  "time": "1435",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06llq02r2g29fp.pdf",
  "summary": "### Summary of ASX Announcement: InhaleRx Limited (ASX:IRX)  \n\n#### **Director Securities Issuance (Performance Rights & Options)**  \n- **Performance Rights Issued** (in lieu of director fees):  \n  - Sean Williams: 1,074,866 rights ($42,732 value at $0.040 per right).  \n  - Dr. Ron Wise: 746,736 rights ($29,687 value).  \n  - Anthony Fitzgerald: 503,324 rights ($20,010 value).  \n  - **Total Rights Issued**: 2,324,926 (based on 30-day VWAP of $0.040).  \n\n- **Unlisted Options Issued**:  \n  - Dr. Ron Wise: 500,000 options ($0.12 strike, expiry 7/7/2028).  \n  - Anthony Fitzgerald: 500,000 options ($0.12 strike, expiry 7/7/2028).  \n\n#### **Context**  \n- Approved by shareholders at AGM (29 May 2025).  \n- No impact on cash position (non-cash remuneration).  \n\n**No material trading or capital markets impact identified.**",
  "usage": {
    "prompt_tokens": 3651,
    "completion_tokens": 249,
    "total_tokens": 3900,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-08T05:47:56.734209"
}